Citigroup’s Foundation Medicine FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-8,000
Closed -$1.09M – 7989
2018
Q2
$1.09M Sell
8,000
-1,900
-19% -$173K ﹤0.01% 3268
2018
Q1
$780K Buy
9,900
+6,200
+168% +$457K ﹤0.01% 3505
2017
Q4
$252K Buy
+3,700
New +$192K ﹤0.01% 4831
2017
Q3
– Sell
-4,500
Closed -$179K – 7592
2017
Q2
$179K Buy
4,500
+1,700
+61% +$62.2K ﹤0.01% 4903
2017
Q1
$90K Hold
2,800
– – ﹤0.01% 5285
2016
Q4
$50K Buy
+2,800
New +$60.3K ﹤0.01% 6146

Citigroup's FMI Position: Q3 2018 in Review

Citigroup sold out of Foundation Medicine (FMI) in Q3 2018, closing a stake of 173,037 shares — an estimated $23.7M sold.

Citigroup first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $23.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • Citigroup reported no remaining Foundation Medicine position as of Q3 2018 after selling out during the quarter.
  • Citigroup sold 173,037 Foundation Medicine shares in Q3 2018, an estimated $23.7M.
  • Citigroup first reported a position in Foundation Medicine in Q4 2013 and held it in 19 quarters.
  • Citigroup's Foundation Medicine position peaked at $23.7M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine as of Q3 2018.

Based on Citigroup's 13F filing for Q3 2018, filed 13 Nov 2018.